A case of severe coagulation disorder caused by cefoperazone sodium and sulbactam
-
摘要:
<正>1临床资料患者女性,31岁,因"全腹胀痛,恶心、呕吐1天余"于2016年8月22日入本院。既往体健。入院查体:体温36.4℃,脉搏95次/min,血压110/70 mm Hg,呼吸18次/min。一般状态尚可,全身皮肤、巩膜无黄染,未见肝掌、蜘蛛痣;双肺呼吸音粗,可闻及少许湿啰音;心率95次/min,律整。腹部膨隆,中上腹有压痛,伴有反跳痛、腹肌紧张。血常规:白细胞19.24×109/L,中性粒细胞百分比0.92,血红蛋白150 g/L,血小板207
-
Key words:
- pancreatitis /
- case reports
-
[1]COHEN MS, WASHTON HE, BARRANCO SF.Multicenter clinical trial of cefoperazone sodium in the United States[J].Am J Med, 1984, 77 (1B) :35-41. [2]GAO C, TONG J, YU K, et al.Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration[J].Eur J Clin Pharmacol, 2016, 72 (7) :823-830. [3]TANG Y, HUANG YP, JIN WH, et al.Effect of sulbactam sodium/cefoperazone sodium on neutrophil extracellular traps of patients with recurrent lower respiratory tract infection[J].J Jilin Univ:Med Edit, 2017, 43 (3) :607-610. (in Chinese) 唐颖, 黄元平, 荆文花, 等.头孢哌酮钠舒巴坦钠对反复下呼吸道感染患者中性粒细胞胞外网状陷阱形成的影响[J].吉林大学学报:医学版, 2017, 43 (3) :607-610. [4]ZOU XF, WU GL, WANG W, et al.Bile and blood bacterial lfora and its antibiotic sensitivity in patients with acute cholangitis combined with choledocholithiasis[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2015, 9 (1) :91-95. (in Chinese) 邹雪飞, 吴广利, 王伟, 等.胆石症合并急性胆管炎患者胆汁及血液病原菌培养及药敏分析[J/CD].中华实验和临床感染病杂志:电子版, 2015, 9 (1) :91-95. [5]DRAWZ SM, BONOMO RA.Three decades of beta-lactamase inhibitors[J].Clin Microbiol Rev, 2010, 23 (1) :160-201. [6]XIN X, JIAN L, XIA X, et al.A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections[J].Ann Clin Microbiol Antimicrob, 2013, 12:38. [7]LOU LL, ZHAO X, WANG SR, et al.Cefoperazone/sulbactam sodium-induced severe coagulation disorder in treatment of moderately severe acute pancreatitis:a case report[J].J Clin Hepatol, 2017, 33 (1) :167-168. (in Chinese) 娄丽丽, 赵旭, 王思睿, 等.舒普深致中重症急性胰腺炎严重凝血功能障碍1例报告[J].临床肝胆病杂志, 2017, 33 (1) :167-168. [8]MITRA S, BASU S.Cefoperazone/sulbactam induced hyponatremia[J].Indian J Med Sci, 2006, 60 (4) :158-159. [9]CAI Z, YANG W, HE Y, et al.Cefoperazone/Sulbactam-induced abdominal wall hematoma and upper gastrointestinal bleeding:a case report and review of the literature[J].Drug Saf Case Rep, 2016, 3 (1) :2. [10]KATUKURI GR, MADDALA RN, RAMAMOORTHI K, et al.Cefoperazone induced gastrointestinal bleeding[J].J Clin Diagn Res, 2016, 10 (8) :OD10-OD11. [11]SHEARER MJ.Vitamin K deficiency bleeding (VKDB) in early infancy[J].Blood Rev, 2009, 23 (2) :49-59. [12]WANG Y, DING N.Clinical analysis and countermeasures of cefoperazone sodium and sulbactam sodium-induced coagulation abnormalities[J].J Clin Exp Med, 2015, 14 (16) :1397-1399. (in Chinese) 王宇, 丁宁.单用头孢哌酮钠舒巴坦钠致凝血功能异常的临床分析及对策[J].临床和实验医学杂志, 2015, 14 (16) :1397-1399. [13]WEI FH.A case of major bleeding caused by cefoperazone sodium/sulbactam sodium[J].World Notes On Antibiotics, 2015, 36 (4) :201-202. (in Chinese) 韦凤华.头孢哌酮钠/舒巴坦钠引起严重出血1例[J].国外医药 (抗生素分册) , 2015, 36 (4) :201-202.
计量
- 文章访问数: 2404
- HTML全文浏览量: 24
- PDF下载量: 446
- 被引次数: 0